Top Markets
Coin of the day
Kyto Technology and Life Science, Inc. Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc.

KBPH
Clasificación en acciones #34729
Kyto Technology and Life Science, Inc. operates as a venture capital firm,... Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.
Precio por acción
$1.00
Última sincronización: 2023-05-23
Capitalización bursátil
$5.03M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Kyto Technology and Life Science, Inc. (KBPH)
Ganancias de Kyto Technology and Life Science, Inc. (KBPH)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Kyto Technology and Life Science, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Kyto Technology and Life Science, Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$9.17B -
US
$8.07B -
US
- -
SE
$6.24B -
US
$3.70B -
US